Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Anemia

  Free Subscription


Articles published in Am J Hematol

Retrieve available abstracts of 103 articles:
HTML format
Text format



Single Articles


    April 2017
  1. GALADANCI N, Abdullahi SU, Vance LD, Tabari AM, et al
    Feasibility Trial for Primary Stroke Prevention in Children with Sickle Cell Anemia in Nigeria (SPIN Trial).
    Am J Hematol. 2017 Apr 25. doi: 10.1002/ajh.24770.
    PubMed     Text format     Abstract available


  2. RAVINDRAN A, Sankaran J, Jacob EK, Kreuter JD, et al
    High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia.
    Am J Hematol. 2017 Apr 24. doi: 10.1002/ajh.24765.
    PubMed     Text format    


  3. COURONNE L, Tertian G, Boutron A, Picard V, et al
    A Somatic Mosaicism in the G6PD Gene Inducing a Late Onset Chronic non Spherocytic Hemolytic Anemia.
    Am J Hematol. 2017 Apr 10. doi: 10.1002/ajh.24760.
    PubMed     Text format    


  4. HANSEN JW, Sandholdt H, Siersma V, Orskov AD, et al
    "Anemia is present years before myelodysplastic syndrome diagnosis - results from the pre-diagnostic period".
    Am J Hematol. 2017 Apr 6. doi: 10.1002/ajh.24757.
    PubMed     Text format    


    March 2017
  5. NASSIN ML, Vergilio JA, Heeney MM, LaBelle JL, et al
    Neonatal Anemia: Revisiting the Enigmatic Pyknocyte.
    Am J Hematol. 2017 Mar 23. doi: 10.1002/ajh.24731.
    PubMed     Text format    


  6. LEWEN MO, Kavanagh PL, Sobota AE
    A comment on improving transcranial Doppler ultrasonography screening in children with sickle cell anemia.
    Am J Hematol. 2017 Mar 23. doi: 10.1002/ajh.24727.
    PubMed     Text format    


  7. MEKONTSO DESSAP A, Cecchini J, Chaar V, Marcos E, et al
    Telomere attrition in sickle cell anemia.
    Am J Hematol. 2017 Mar 15. doi: 10.1002/ajh.24721.
    PubMed     Text format    


  8. FARRUGGIA P, Puccio G, Ramenghi U, Colombatti R, et al
    Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: A retrospective cohort study of A.I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica).
    Am J Hematol. 2017 Mar 6. doi: 10.1002/ajh.24713.
    PubMed     Text format    


  9. PATNAIK MM, Tefferi A
    Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management.
    Am J Hematol. 2017;92:297-310.
    PubMed     Text format     Abstract available


    February 2017
  10. HANSEN BR, Bottner WA, Ravindran A, DeJesus R, et al
    Desiderosmia (olfactory craving): A novel symptom associated with iron deficiency anemia.
    Am J Hematol. 2017 Feb 27. doi: 10.1002/ajh.24706.
    PubMed     Text format    


  11. LEAF RK, O'Brien KL, Leaf DE, Drews RE, et al
    Autoimmune hemolytic anemia in a young man with acute hepatitis E infection.
    Am J Hematol. 2017 Feb 23. doi: 10.1002/ajh.24699.
    PubMed     Text format    


  12. WHIPPLE NS, Schwartz JR, Nottage KA
    DAT-positive Plasmodium ovale malaria presenting in a child with sickle cell anemia.
    Am J Hematol. 2017 Feb 17. doi: 10.1002/ajh.24691.
    PubMed     Text format    


  13. ALELUIA MM, Santiago RP, da Guarda CC, Fonseca TC, et al
    Genetic Modulation of Fetal Hemoglobin in Hydroxyurea-Treated Sickle Cell Anemia.
    Am J Hematol. 2017 Feb 13. doi: 10.1002/ajh.24680.
    PubMed     Text format    


  14. CHATURVEDI S, Labib Ghafuri D, Kassim A, Rodeghier M, et al
    Elevated tricuspid regurgitant jet velocity, reduced forced expiratory volume in 1 second, and mortality in adults with sickle cell disease.
    Am J Hematol. 2017;92:125-130.
    PubMed     Text format     Abstract available


    January 2017
  15. DERMAN R, Roman E, Modiano MR, Okam MM, et al
    A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
    Am J Hematol. 2017 Jan 4. doi: 10.1002/ajh.24633.
    PubMed     Text format     Abstract available


    December 2016
  16. JACOB SA, Novelli EM, Isenberg JS, Garrett ME, et al
    Thrombospondin-1 Gene Polymorphism is Associated with Estimated Pulmonary Artery Pressure in Patients with Sickle Cell Anemia.
    Am J Hematol. 2016 Dec 29. doi: 10.1002/ajh.24635.
    PubMed     Text format    


  17. RICCHI P, Costantini S, Spasiano A, Di Matola T, et al
    Myelolipoma among patients with thalassemia major and rare anemia with iron loading: A not so rare entity.
    Am J Hematol. 2016 Dec 22. doi: 10.1002/ajh.24622.
    PubMed     Text format    


  18. BAIN BJ
    Howell-Jolly bodies in acute hemolytic anemia.
    Am J Hematol. 2016 Dec 22. doi: 10.1002/ajh.24624.
    PubMed     Text format    


    October 2016
  19. GOODNOUGH LT, Comin-Colet J, Leal-Noval S, Ozawa S, et al
    Management of Anemia in Patients with Congestive Heart Failure.
    Am J Hematol. 2016 Oct 25. doi: 10.1002/ajh.24595.
    PubMed     Text format     Abstract available


  20. QUARMYNE MO, Dong W, Theodore R, Anand S, et al
    Hydroxyurea Effectiveness in Children and Adolescents with Sickle Cell Anemia: A Large Retrospective, Population-Based Cohort.
    Am J Hematol. 2016 Oct 19. doi: 10.1002/ajh.24587.
    PubMed     Text format     Abstract available


  21. MICHEL M, Terriou L, Roudot-Thoraval F, Hamidou M, et al
    A Randomized and Double-Blind Controlled Trial Evaluating the Safety and Efficacy of Rituximab for Warm Auto-Immune Hemolytic Anemia in Adults (the RAIHA study).
    Am J Hematol. 2016 Oct 3. doi: 10.1002/ajh.24570.
    PubMed     Text format     Abstract available


    September 2016
  22. QUINN CT, Smith EP, Arbabi S, Khera PK, et al
    Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia.
    Am J Hematol. 2016 Sep 20. doi: 10.1002/ajh.24562.
    PubMed     Text format     Abstract available


  23. DONKER AE, Schaap CC, Novotny VM, Smeets R, et al
    Iron Refractory Iron Deficiency Anemia (IRIDA): A heterogeneous disease that is not always iron refractory.
    Am J Hematol. 2016 Sep 19. doi: 10.1002/ajh.24561.
    PubMed     Text format     Abstract available


  24. DEITERING S, Anslemo L, Burnett A, Jakeman B, et al
    Safety and effectiveness of extended versus shortened iron dextran infusion time for the treatment of iron deficiency anemia.
    Am J Hematol. 2016 Sep 15. doi: 10.1002/ajh.24555.
    PubMed     Text format    


  25. ATTA M, Brannigan ET, Bain BJ
    Cold autoimmune hemolytic anemia secondary to atypical pneumonia.
    Am J Hematol. 2016 Sep 6. doi: 10.1002/ajh.24550.
    PubMed     Text format    


    August 2016
  26. NARLA A, Davis NL, LaVasseur C, Wong C, et al
    Erythrocyte adenosine deaminase levels are elevated in Diamond Blackfan anemia but not in the 5q- syndrome.
    Am J Hematol. 2016 Aug 24. doi: 10.1002/ajh.24541.
    PubMed     Text format    


  27. CHATURVEDI S, Ghafuri DL, Glassberg J, Kassim AA, et al
    Rapidly progressive acute chest syndrome in individuals with sickle cell anemia.
    Am J Hematol. 2016 Aug 20. doi: 10.1002/ajh.24539.
    PubMed     Text format     Abstract available


  28. VATHIPADIEKAL V, Farrell JJ, Wang S, Edward HL, et al
    A Candidate Trans-acting Modulator of Fetal Hemoglobin Gene Expression in the Arab-Indian Haplotype of Sickle Cell Anemia: -ANTXR1 Variants and HbF.
    Am J Hematol. 2016 Aug 7. doi: 10.1002/ajh.24527.
    PubMed     Text format     Abstract available


    July 2016
  29. STEVENS H, Chua CC, Wallis M, Hew S, et al
    Fanconi anemia in 55 year-old identical twins first presenting as fatal post-chemotherapy pancytopenia.
    Am J Hematol. 2016 Jul 18. doi: 10.1002/ajh.24488.
    PubMed     Text format    


    June 2016
  30. CAOCCI G, La Nasa G, Bain BJ
    Erythroblast morphology in refractory anemia with ring sideroblasts.
    Am J Hematol. 2016 Jun 14. doi: 10.1002/ajh.24448.
    PubMed     Text format    


  31. VATHIPADIEKAL V, Alsultan A, Baltrusaitis K, Farrell JJ, et al
    Homozygosity for a haplotype in the HBG2-OR51B4 region is exclusive to Arab-Indian haplotype sickle cell anemia.
    Am J Hematol. 2016;91:E308-11.
    PubMed     Text format    


  32. RISITANO AM
    Paroxysmal nocturnal hemoglobinuria in the era of complement inhibition.
    Am J Hematol. 2016;91:359-60.
    PubMed     Text format    


  33. SHIREL T, Hubler CP, Shah R, Mager AB, et al
    Maternal opioid dose is associated with neonatal abstinence syndrome in children born to women with sickle cell disease.
    Am J Hematol. 2016;91:416-9.
    PubMed     Text format     Abstract available


  34. LOSCHI M, Porcher R, Barraco F, Terriou L, et al
    Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
    Am J Hematol. 2016;91:366-70.
    PubMed     Text format     Abstract available


    May 2016
  35. BALANDYA E, Reynolds T, Obaro S, Makani J, et al
    Alteration of Lymphocyte Phenotype and Function in Sickle Cell Anemia: Implications for Vaccine Responses.
    Am J Hematol. 2016 May 30. doi: 10.1002/ajh.24438.
    PubMed     Text format     Abstract available


  36. RISHI G, Secondes ES, Wallace DF, Subramaniam VN, et al
    Hematopoietic deletion of Transferrin Receptor 2 in mice leads to a block in erythroid differentiation during iron-deficient anemia.
    Am J Hematol. 2016 May 11. doi: 10.1002/ajh.24417.
    PubMed     Text format     Abstract available


  37. HEXNER EO, Luger SM, Reshef R, Jeschke GR, et al
    Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.
    Am J Hematol. 2016;91:453-60.
    PubMed     Text format     Abstract available


  38. KAMMEYER R, Devnani R, Mehta R
    Cerebral fat embolism syndrome mimicking thrombotic thrombocytopenic purpura in a patient with hemoglobin SC disease.
    Am J Hematol. 2016;91:539-42.
    PubMed     Text format    


    April 2016
  39. URIO F, Lyimo M, Mtatiro SN, Cox SE, et al
    High Prevalence of Individuals with Low Concentration of Fetal Hemoglobin in F-cells in Sickle Cell Anemia in Tanzania.
    Am J Hematol. 2016 Apr 16. doi: 10.1002/ajh.24390.
    PubMed     Text format    


  40. MAURO FR, Coluzzi S, Paoloni F, Trastulli F, et al
    "Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up".
    Am J Hematol. 2016 Apr 5. doi: 10.1002/ajh.24379.
    PubMed     Text format    


    March 2016
  41. SVAHN J, Bagnasco F, Cappelli E, Onofrillo D, et al
    Somatic, hematologic phenotype, long-term outcome and effect of hematopoietic stem cell transplantation. An analysis of 97 Fanconi Anemia patients from the Italian national database on behalf of the Marrow Failure Study Group of the AIEOP (Italian Ass
    Am J Hematol. 2016 Mar 25. doi: 10.1002/ajh.24373.
    PubMed     Text format     Abstract available


  42. O'CONNELL C, Horwood K, Nadamuni M
    Correction of refractory thrombocytopenia and anemia following withdrawal of extended release niacin.
    Am J Hematol. 2016 Mar 25. doi: 10.1002/ajh.24371.
    PubMed     Text format    


  43. WONG L, Smith S, Gilstrop M, Derman R, et al
    Safety and Efficacy of Rapid (1000 mg in one hour) Intravenous Iron Dextran for Treatment of Maternal Iron Deficient Anemia.
    Am J Hematol. 2016 Mar 11. doi: 10.1002/ajh.24361.
    PubMed     Text format     Abstract available


  44. SADREAMELI SC, Eakin MN, Robinson KT, Alade RO, et al
    Secondhand smoke is associated with more frequent hospitalizations in children with sickle cell disease.
    Am J Hematol. 2016;91:313-7.
    PubMed     Text format     Abstract available


  45. HILLMEN P, Muus P, Szer J, Hill A, et al
    Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria.
    Am J Hematol. 2016;91:E16-7.
    PubMed     Text format    


  46. KNAPP E, Cohen H, Kutlar A, Ghalie R, et al
    Intrapatient variability in fetal hemoglobin measurements over time in sickle cell patients not on fetal hemoglobin inducing agents.
    Am J Hematol. 2016;91:E11-2.
    PubMed     Text format    


    February 2016
  47. PATNAIK MM, Lasho TL, Finke CM, Hanson CA, et al
    Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing.
    Am J Hematol. 2016 Feb 13. doi: 10.1002/ajh.24332.
    PubMed     Text format     Abstract available


  48. PARTAIN DK, Botero JP, Shi M, Poterucha JJ, et al
    Spur Cell Anemia in the Setting of Progressive Liver Allograft Failure.
    Am J Hematol. 2016 Feb 13. doi: 10.1002/ajh.24331.
    PubMed     Text format    


  49. LUCHTMAN-JONES L, Pressel S, Hilliard L, Brown RC, et al
    Effects of hydroxyurea treatment for patients with hemoglobin SC disease.
    Am J Hematol. 2016;91:238-42.
    PubMed     Text format     Abstract available


  50. MCGANN PT, Schaefer BA, Paniagua M, Howard TA, et al
    Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease.
    Am J Hematol. 2016;91:205-10.
    PubMed     Text format     Abstract available


  51. ANEA CB, Lyon M, Lee IA, Gonzales JN, et al
    Pulmonary platelet thrombi and vascular pathology in acute chest syndrome in patients with sickle cell disease.
    Am J Hematol. 2016;91:173-8.
    PubMed     Text format     Abstract available


  52. LAYTON DM, Bain BJ
    Dehydrated hereditary stomatocytosis.
    Am J Hematol. 2016;91:266.
    PubMed     Text format    


    January 2016
  53. BOUCHNITA A, Eymard N, Moyo TK, Koury MJ, et al
    Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.
    Am J Hematol. 2016 Jan 9. doi: 10.1002/ajh.24291.
    PubMed     Text format     Abstract available


  54. CHATURVEDI S, DeBaun MR
    Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.
    Am J Hematol. 2016;91:5-14.
    PubMed     Text format     Abstract available


  55. RUND D
    Thalassemia 2016: Modern medicine battles an ancient disease.
    Am J Hematol. 2016;91:15-21.
    PubMed     Text format     Abstract available


  56. MINNITI CP, Kato GJ
    Critical Reviews: How we treat sickle cell patients with leg ulcers.
    Am J Hematol. 2016;91:22-30.
    PubMed     Text format     Abstract available


    November 2015
  57. BABUSHOK DV, Grignon AL, Li Y, Atienza J, et al
    Disrupted lymphocyte homeostasis in hepatitis-associated acquired aplastic anemia is associated with short telomeres.
    Am J Hematol. 2015 Nov 30. doi: 10.1002/ajh.24256.
    PubMed     Text format     Abstract available


  58. TEFFERI A, Cerquozzi S, Liaw J
    Bendamustine therapy associated resolution of anemia and splenomegaly in myelofibrosis.
    Am J Hematol. 2015 Nov 20. doi: 10.1002/ajh.24248.
    PubMed     Text format    


  59. VADHAN-RAJ S, Ford DC, Dahl NV, Bernard K, et al
    Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study.
    Am J Hematol. 2015 Nov 17. doi: 10.1002/ajh.24240.
    PubMed     Text format    


  60. FILLIATRE L, Broseus J, Pissard S, Mekki C, et al
    Amyl nitrite inhalation, a "volatile" anemia.
    Am J Hematol. 2015 Nov 3. doi: 10.1002/ajh.24229.
    PubMed     Text format    


  61. FOUQUET G, Guidez S, Petillon MO, Louni C, et al
    Lenalidomide is safe and active in Waldenstrom macroglobulinemia.
    Am J Hematol. 2015;90:1055-9.
    PubMed     Text format     Abstract available


  62. RICCHI P, Meloni A, Spasiano A, Neri MG, et al
    Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients.
    Am J Hematol. 2015;90:1008-12.
    PubMed     Text format     Abstract available


    October 2015
  63. GARDNER K, Thein SL
    Super-elevated LDH and thrombocytopenia are markers of a severe subtype of vaso-occlusive crisis in sickle cell disease.
    Am J Hematol. 2015;90:E206-7.
    PubMed     Text format    


  64. ANDOLFO I, Russo R, Manna F, Shmukler BE, et al
    Novel Gardos channel mutations linked to dehydrated hereditary stomatocytosis (xerocytosis).
    Am J Hematol. 2015;90:921-6.
    PubMed     Text format     Abstract available


    September 2015
  65. HANKINS JS, McCarville MB, Rankine-Mullings A, Reid ME, et al
    Prevention of conversion to abnormal tcd with hydroxyurea in sickle cell anemia: A phase III international randomized clinical trial.
    Am J Hematol. 2015 Sep 28. doi: 10.1002/ajh.24198.
    PubMed     Text format     Abstract available


  66. AUERBACH M, Adamson JW
    How We Diagnose and Treat Iron Deficiency Anemia.
    Am J Hematol. 2015 Sep 26. doi: 10.1002/ajh.24201.
    PubMed     Text format     Abstract available


  67. CASTRO O, Kato GJ
    Iron restriction in sickle cell anemia: Time for controlled clinical studies.
    Am J Hematol. 2015 Sep 16. doi: 10.1002/ajh.24193.
    PubMed     Text format    


  68. FREEMAN AT, Ataga KI
    Pulmonary Endarterectomy as Treatment for Chronic Thromboembolic Pulmonary Hypertension in Sickle Cell Disease.
    Am J Hematol. 2015 Sep 15. doi: 10.1002/ajh.24192.
    PubMed     Text format    


  69. SALIBA AN, Taher AT
    Comment on "deferiprone versus deferoxamine in thalassemia intermedia: results from a 5-year long-term Italian multicenter randomized clinical trial".
    Am J Hematol. 2015;90:E192-3.
    PubMed     Text format    


  70. LUND K, Chakravorty S, Toma S, Bain BJ, et al
    Compound heterozygosity for hemoglobins S and D.
    Am J Hematol. 2015;90:842.
    PubMed     Text format    


  71. O'REILLY MA, Millar SR, Buckley CM, Harrington JM, et al
    Smoking as an independent risk factor for macrocytosis in middle-aged adults: a population-based observational study.
    Am J Hematol. 2015;90:E196-7.
    PubMed     Text format    


  72. CHANDRAN R, Moran A, Barash M, Hopper B, et al
    A case of acute chest syndrome complicated by diffuse cerebral infarcts in an adult with HbSbeta-thalassemia(.).
    Am J Hematol. 2015;90:E197.
    PubMed     Text format    


  73. GRACE RF, Zanella A, Neufeld EJ, Morton DH, et al
    Erythrocyte pyruvate kinase deficiency: 2015 status report.
    Am J Hematol. 2015;90:825-30.
    PubMed     Text format     Abstract available


  74. SINGER ST, Killilea D, Suh JH, Wang ZJ, et al
    Fertility in transfusion-dependent thalassemia men: effects of iron burden on the reproductive axis.
    Am J Hematol. 2015;90:E190-2.
    PubMed     Text format    


  75. MELONI A, Restaino G, Missere M, De Marchi D, et al
    Pancreatic iron overload by T2* MRI in a large cohort of well treated thalassemia major patients: can it tell us heart iron distribution and function?
    Am J Hematol. 2015;90:E189-90.
    PubMed     Text format    


  76. CHEN M, Loh SF, Yu SL, Nair S, et al
    Rapid and reliable preimplantation genetic diagnosis of common hemoglobin Bart's hydrops fetalis syndrome and hemoglobin H disease determinants using an enhanced single-tube decaplex polymerase chain reaction assay.
    Am J Hematol. 2015;90:E194-6.
    PubMed     Text format    


  77. KOURELIS TV, Buckner JC, Gangat N, Patnaik MM, et al
    Temozolomide induced bone marrow Suppression--A single institution outcome analysis and review of the literature.
    Am J Hematol. 2015;90:E183-4.
    PubMed     Text format    


    August 2015
  78. MCGANN PT, Tyburski EA, de Oliveira V, Santos B, et al
    An accurate and inexpensive color-based assay for detecting severe anemia in a limited-resource setting.
    Am J Hematol. 2015 Aug 28. doi: 10.1002/ajh.24180.
    PubMed     Text format     Abstract available


  79. DEL MAR MANU-PEREIRA M, Gonzalez-Roca E, van Solinge WW, Llaudet-Planas E, et al
    Pyruvate kinase deficiency and severe congenital hemolytic anemia in a double heterozygous patient with paternal transmission of an early germ-line de novo mutation.
    Am J Hematol. 2015 Aug 28. doi: 10.1002/ajh.24178.
    PubMed     Text format    


  80. HERBAUX C, Duployez N, Badens C, Poret N, et al
    Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis.
    Am J Hematol. 2015;90:737-8.
    PubMed     Text format     Abstract available


  81. DESAI PC, Deal AM, Pfaff ER, Qaqish B, et al
    Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease.
    Am J Hematol. 2015;90:691-5.
    PubMed     Text format     Abstract available


  82. FATTIZZO B, Zaninoni A, Nesa F, Sciumbata VM, et al
    Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias.
    Am J Hematol. 2015;90:E149-51.
    PubMed     Text format    


  83. GIRI N, Alter BP, Penrose K, Falk RT, et al
    Immune status of patients with inherited bone marrow failure syndromes.
    Am J Hematol. 2015;90:702-8.
    PubMed     Text format     Abstract available


    July 2015
  84. ARCHER N, Galacteros F, Brugnara C
    2015 Clinical Trials Update in Sickle Cell Anemia.
    Am J Hematol. 2015 Jul 15. doi: 10.1002/ajh.24116.
    PubMed     Text format     Abstract available


  85. STEENSMA DP, Dakhil SR, Novotny PJ, Sloan JA, et al
    A Randomized Comparison of Once Weekly Epoetin Alfa to Extended Schedule Epoetin or Darbepoetin in Chemotherapy-Associated Anemia.
    Am J Hematol. 2015 Jul 6. doi: 10.1002/ajh.24110.
    PubMed     Text format     Abstract available


  86. ADEKILE A, Menzel S, Gupta R, Al-Sharida S, et al
    Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels.
    Am J Hematol. 2015;90:E138-9.
    PubMed     Text format    


  87. FOZZA C, Pardini S, Giannico DB, Targhetta C, et al
    Dramatic erythroid response to low-dose thalidomide in two patients with transfusion independent thalassemia and severe post-transfusional alloimmune hemolysis.
    Am J Hematol. 2015;90:E141.
    PubMed     Text format    


  88. CALVARUSO G, Vitrano A, Di Maggio R, Lai E, et al
    Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5-year long-term Italian multicenter randomized clinical trial.
    Am J Hematol. 2015;90:634-8.
    PubMed     Text format     Abstract available


  89. JASPERS A, Baron F, Maertens J, De Prijck B, et al
    Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation.
    Am J Hematol. 2015;90:E133-4.
    PubMed     Text format    


    June 2015
  90. JASPERS A, Baron F, Servais S, Lejeune M, et al
    Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survival.
    Am J Hematol. 2015 Jun 25. doi: 10.1002/ajh.24100.
    PubMed     Text format    


  91. WOOD JC, Pressel S, Rogers ZR, Odame I, et al
    Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: Baseline results from the TWiTCH trial.
    Am J Hematol. 2015 Jun 19. doi: 10.1002/ajh.24089.
    PubMed     Text format     Abstract available


  92. PIETY NZ, Yang X, Lezzar D, George A, et al
    A rapid paper-based test for quantifying sickle hemoglobin in blood samples from patients with sickle cell disease.
    Am J Hematol. 2015;90:478-82.
    PubMed     Text format     Abstract available


    May 2015
  93. NICHELE I, Ruggeri M, Rodeghiero F
    Effectiveness of lenalidomide in a patient with refractory anemia with ring sideroblasts and thrombocytosis with JAK2 (V617F) mutation.
    Am J Hematol. 2015 May 11. doi: 10.1002/ajh.24049.
    PubMed     Text format    


  94. RENELLA R
    Age-dependent pathophysiology of acute chest syndrome in children with sickle cell disease.
    Am J Hematol. 2015;90:367-8.
    PubMed     Text format    


  95. FIANCHI L, Pagano L, Piciocchi A, Candoni A, et al
    Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias.
    Am J Hematol. 2015;90:E80-5.
    PubMed     Text format     Abstract available


  96. FERRONE FA
    The delay time in sickle cell disease after 40 years: A paradigm assessed.
    Am J Hematol. 2015;90:438-45.
    PubMed     Text format     Abstract available


  97. LANZKRON S, Carroll CP, Hill P, David M, et al
    Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis.
    Am J Hematol. 2015;90:376-80.
    PubMed     Text format     Abstract available


  98. REESE JA, Bougie DW, Curtis BR, Terrell DR, et al
    Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin.
    Am J Hematol. 2015;90:406-10.
    PubMed     Text format     Abstract available


  99. MANWANI D, Chen G, Carullo V, Serban S, et al
    Single-dose intravenous gammaglobulin can stabilize neutrophil Mac-1 activation in sickle cell pain crisis.
    Am J Hematol. 2015;90:381-5.
    PubMed     Text format     Abstract available


    April 2015
  100. PICOT J, Ndour PA, Lefevre SD, El Nemer W, et al
    A biomimetic microfluidic chip to study the circulation and mechanical retention of red blood cells in the spleen.
    Am J Hematol. 2015;90:339-45.
    PubMed     Text format     Abstract available


  101. SAVAGE WJ, Buchanan GR, Yawn BP, Afenyi-Annan AN, et al
    Evidence gaps in the management of sickle cell disease: A summary of needed research.
    Am J Hematol. 2015;90:273-5.
    PubMed     Text format    


  102. SCHIMMEL M, van Beers EJ, van Tuijn CF, Nur E, et al
    N-terminal pro-B-type natriuretic peptide, tricuspid jet flow velocity, and death in adults with sickle cell disease.
    Am J Hematol. 2015;90:E75-6.
    PubMed     Text format    


  103. SCHMIDT PJ, Racie T, Westerman M, Fitzgerald K, et al
    Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of beta-thalassemia intermedia.
    Am J Hematol. 2015;90:310-3.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: